NEW YORK, LONDON, AMSTERDAM, the Netherlands, DUBAI, United Arab Emirates, PUNE, India and SINGAPORE, March 15, 2017 -- Synechron Inc., a global financial services consulting and technology services provider, has today announced the appointment of industry veteran John Gaunt as Chief Human Resources Officer. Gaunt will report directly to Synechron CEO Faisal Husain and will focus on enhancing Synechron’s business operating model across geographies to strengthen its employee engagement, leadership, and employee value proposition.
John brings Synechron over thirty years of international human resource management experience in Financial Services and Technology. He joins Synechron from HCL where as EVP of International HR he managed people operations across 110,000 employees as well as the company’s global delivery centers. As Global Head of HR at Genpact, he oversaw the integration of Headstrong into the business following its acquisition. He also served as Global Head of HR Operations for Geographic Services at Accenture where he supported the company’s expansion into India from 180 to over 200,000 people.
“It is an exciting time for Synechron. Over the last few years we have significantly expanded our global footprint and deepened our service capabilities across Digital, Consulting, and Technology. As we continue on this trajectory and toward our goal to become a $1 Bn business, we need to be prepared for Synechron’s next growth phase. John will play an instrumental role as Synechron continues on that journey,” said Faisal Husain, Co-founder and CEO of Synechron.
“The world is changing rapidly around us, and the ability to engage with people in a way that is new and vibrant is what sets today’s employers apart. Synechron has a young, vibrant, proud, and passionate culture with a highly-personalized, high-touch environment. I’m eager to tap into that energy to find the common thread that binds employees in order to enhance global employee engagement, leadership and the employee value proposition. This will help support Synechron’s continued growth,” added Gaunt.
About Synechron
Synechron is a global consulting and technology organization providing innovative solutions to the financial services industry through its three main business focus areas: digital, business consulting, and technology. Based in New York, the company has 18 offices around the globe, with over 7,000+ employees producing over $400+M in annual revenue. For more information on the Company please visit the website or our LinkedIn community.
For further information, please contact: Synechron Diana Kearns-Manolatos Synechron, Inc. [email protected] m: 1 347-721-8223 UK Dan Williams Rostrum +44 (0)203 727 3740 [email protected] US Vested Hod Klein Vested 917-765-8720 [email protected] India Rajesh Joshi The Good Edge [email protected] m: +91 9833171525


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



